These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 11477321

  • 1. Determination of LSD in urine with high-performance liquid chromatography--mass spectrometry.
    Bodin K, Svensson JO.
    Ther Drug Monit; 2001 Aug; 23(4):389-93. PubMed ID: 11477321
    [Abstract] [Full Text] [Related]

  • 2. Liquid chromatography-electrospray ionization mass spectrometry for the detection of lysergide and a major metabolite, 2-oxo-3-hydroxy-LSD, in urine and blood.
    Sklerov JH, Magluilo J, Shannon KK, Smith ML.
    J Anal Toxicol; 2000 Oct; 24(7):543-9. PubMed ID: 11043657
    [Abstract] [Full Text] [Related]

  • 3. Liquid chromatography-atmospheric pressure ionization electrospray mass spectrometry determination of "hallucinogenic designer drugs" in urine of consumers.
    Pichini S, Pujadas M, Marchei E, Pellegrini M, Fiz J, Pacifici R, Zuccaro P, Farré M, de la Torre R.
    J Pharm Biomed Anal; 2008 Jun 09; 47(2):335-42. PubMed ID: 18262381
    [Abstract] [Full Text] [Related]

  • 4. The determination of lysergide (LSD) in urine by high-performance liquid chromatography-isotope dilution mass spectrometry (IDMS).
    White SA, Kidd AS, Webb KS.
    J Forensic Sci; 1999 Mar 09; 44(2):375-9. PubMed ID: 10097366
    [Abstract] [Full Text] [Related]

  • 5. Quantitation of lysergic acid diethylamide in urine using atmospheric pressure matrix-assisted laser desorption/ionization ion trap mass spectrometry.
    Cui M, McCooeye MA, Fraser C, Mester Z.
    Anal Chem; 2004 Dec 01; 76(23):7143-8. PubMed ID: 15571372
    [Abstract] [Full Text] [Related]

  • 6. The development and application of a gas chromatography-mass spectrometric (GC-MS) assay to determine the presence of 2-oxo-3-hydroxy-LSD in urine.
    Burnley BT, George S.
    J Anal Toxicol; 2003 Dec 01; 27(4):249-52. PubMed ID: 12820748
    [Abstract] [Full Text] [Related]

  • 7. Determination of buprenorphine, fentanyl and LSD in whole blood by UPLC-MS-MS.
    Berg T, Jørgenrud B, Strand DH.
    J Anal Toxicol; 2013 Apr 01; 37(3):159-65. PubMed ID: 23423312
    [Abstract] [Full Text] [Related]

  • 8. Liquid chromatography-tandem mass spectrometry method for the simultaneous analysis of multiple hallucinogens, chlorpheniramine, ketamine, ritalinic acid, and metabolites, in urine.
    del Mar Ramirez Fernandez M, Laloup M, Wood M, De Boeck G, Lopez-Rivadulla M, Wallemacq P, Samyn N.
    J Anal Toxicol; 2007 Oct 01; 31(8):497-504. PubMed ID: 17988464
    [Abstract] [Full Text] [Related]

  • 9. Automated extraction of lysergic acid diethylamide (LSD) and N-demethyl-LSD from blood, serum, plasma, and urine samples using the Zymark RapidTrace with LC/MS/MS confirmation.
    de Kanel J, Vickery WE, Waldner B, Monahan RM, Diamond FX.
    J Forensic Sci; 1998 May 01; 43(3):622-5. PubMed ID: 9608700
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Determination of LSD and N-demethyl-LSD in urine by liquid chromatography coupled to electrospray ionization mass spectrometry.
    Hoja H, Marquet P, Verneuil B, Lotfi H, Dupuy JL, Lachâtre G.
    J Chromatogr B Biomed Sci Appl; 1997 May 09; 692(2):329-35. PubMed ID: 9188821
    [Abstract] [Full Text] [Related]

  • 12. Determination of LSD and its metabolites in human biological fluids by high-performance liquid chromatography with electrospray tandem mass spectrometry.
    Canezin J, Cailleux A, Turcant A, Le Bouil A, Harry P, Allain P.
    J Chromatogr B Biomed Sci Appl; 2001 Dec 05; 765(1):15-27. PubMed ID: 11817305
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Determination of lysergide in urine by high-performance liquid chromatography combined with electrospray ionisation mass spectrometry.
    White SA, Catterick T, Harrison ME, Johnston DE, Reed GD, Webb KS.
    J Chromatogr B Biomed Sci Appl; 1997 Feb 21; 689(2):335-40. PubMed ID: 9080319
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. LC-ESI-MS/MS on an ion trap for the determination of LSD, iso-LSD, nor-LSD and 2-oxo-3-hydroxy-LSD in blood, urine and vitreous humor.
    Favretto D, Frison G, Maietti S, Ferrara SD.
    Int J Legal Med; 2007 Jul 21; 121(4):259-65. PubMed ID: 16496170
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of the diagnostic performance of the Boehringer Mannheim CEDIA LSD assay.
    Verstraete AG, Steyaert S.
    J Anal Toxicol; 1998 Jul 21; 22(7):601-4. PubMed ID: 9847012
    [Abstract] [Full Text] [Related]

  • 19. Quantitative determination of LSD and a major metabolite, 2-oxo-3-hydroxy-LSD, in human urine by solid-phase extraction and gas chromatography-tandem mass spectrometry.
    Reuschel SA, Percey SE, Liu S, Eades DM, Foltz RL.
    J Anal Toxicol; 1999 Sep 21; 23(5):306-12. PubMed ID: 10488916
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.